Ocular Therapeutix, Inc. (OCUL) vs Stoke Therapeutics, Inc. (STOK)
- Ocular Therapeutix, Inc. OCUL 6.87 −6.91%
- Stoke Therapeutics, Inc. STOK 24.17 −1.79%
Ocular Therapeutix, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Ocular Therapeutix, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Ocular Therapeutix, Inc. grew revenue faster over the last twelve months: −8.14% against −86.2%. Ocular Therapeutix, Inc. has the higher net margin (−579.1% vs −753.6%) and the higher return on invested capital (0.00% vs −264.8%). Across the 17 metrics below, Ocular Therapeutix, Inc. leads on 10 and Stoke Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | OCUL | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.11% | 100.00% | 65.16% |
| Operating margin | (603.04%) | (809.69%) | 0.00% |
| Net margin | (579.10%) | (753.60%) | 0.00% |
| Free cash flow margin | (490.07%) | (654.92%) | 0.00% |
| Return on equity | (72.99%) | (61.10%) | (56.36%) |
| Return on assets | (53.70%) | (53.41%) | (48.04%) |
| Return on invested capital | 0.00% | (264.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack